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Trypanosoma brucei, the causative agent of sleeping sickness, possesses
the metabolic machinery for de novo synthesis of pyrimidine nucleotides
but also has the capacity to obtain pyrimidines from the host via the
salvage pathway. This parasite lacks the dCMP deaminase responsible for
dUMP formation present in mammalian cells however it does contain a pu-
tative cytidine deaminase (TbCDA). We previously reported that T. bru-
cei deoxyuridine triphosphate nucleotidohydrolase null mutants are thymi-
dine (dThd) auxotrophs although 5-methyl-2’-deoxycytidine (5mdC) can
also support growth presumably through deamination to yield dThd thus
suggesting an important role of TbCDA in pyrimidine nucleoside homeos-
tasis. We have characterized recombinant TbCDA and show that it ca-
talyzes deamination of cytidine (Ctd) or deoxycytidine (dCtd) to uridine
(Urd) and deoxyuridine (dUrd) respectively. TbCDA is also capable of
deaminating several nucleoside analogues, such as 5mdC. In agreement
with this observation, T. brucei bloodstream forms overexpressing TbC-
DA are hypersensitive to the analogue 5fdC. Cellular localization studies
revealed that TbCDA is a mitochondrial enzyme in both procyclic and
bloodstream forms of the parasite. RNAi-mediated depletion of the enzy-
me in T. brucei bloodstream forms resulted in defective growth in the
absence of external pyrimidines. The defective growth phenotype is rever-
sed by dThd supplementation further supporting the notion that TbCDA
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is crucially involved in providing dUrd for de novo dTMP biosynthesis
and may constitute a target for therapeutic intervention in kinetoplastid
diseases.
